Toleranzia AB
TOL | ST
Overview
Corporate Details
- ISIN(s):
- SE0007438577 (+1 more)
- LEI:
- 529900ARVN1D3A4CHI81
- Country:
- Sweden
- Address:
- Arvid Wallgrens backe 20, 413 46 Göteborg
- Website:
- https://toleranzia.se/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Toleranzia AB is a biotechnology company developing therapies that utilize the immune system to treat rare autoimmune (orphan) diseases. The company's approach focuses on targeting the underlying cause of a disease, aiming to create curative or long-acting treatments that go beyond symptom management. Its lead drug candidate, TOL2, is in development for the treatment of the neuromuscular disease myasthenia gravis (MG). Toleranzia's pipeline also includes TOL3, a candidate for the treatment of the autoimmune blood vessel disease ANCA-vasculitis.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Toleranzia AB.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Toleranzia AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Toleranzia AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-04-04 | Thomas Eldered | Other | Sell | 12,000,000 | 5,100,000.00 SEK |
| 2025-04-03 | Thomas Eldered | Other | Sell | 23,764,705 | 10,099,999.62 SEK |
